In DM patients, clinical trials of pioglitazone as a single therapy or combined with metformin, insulin or sulfonylurea drugs showed that short-term and long-term glycemic control and lipid profiles are significantly improved10. The gene discussed is INS; the disease is diabetes mellitus.